Pentwater Capital Management LP, 10% Owner at Tobira Therapeutics, Inc. (TBRA), bought 1,705,191 shares at $38.87 ($66.6M) on 2016-09-20, disclosed to the SEC on 2016-09-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.87 | 220,000 | $8.6M | 12.8% |
| 2 | $39.03 | 1,070,000 | $41.8M | 62.7% |
| 3 | $39.07 | 5,000 | $195K | 0.3% |
| 4 | $39.23 | 1,000 | $39K | 0.1% |
| 5 | $38.97 | 31,000 | $1.2M | 1.8% |
| 6 | $39.12 | 3,200 |
| $125K |
| 0.2% |
| 7 | $39.12 | 3,200 | $125K | 0.2% |
| 8 | $39.14 | 195,000 | $7.6M | 11.5% |
| 9 | $39.26 | 1,209 | $47K | 0.1% |
| 10 | $39.30 | 50,000 | $2.0M | 3.0% |
| 11 | $39.30 | 50,000 | $2.0M | 3.0% |
| 12 | $39.40 | 27,791 | $1.1M | 1.6% |
| 13 | $39.40 | 27,791 | $1.1M | 1.6% |
| 14 | $39.45 | 20,000 | $789K | 1.2% |
| Total | $39.05 avg | 1,705,191 | $66.6M | 100% |
| Filing → |
| CAR | SELL | 2026-04-28 | $223.1M | — | Filing → |
| CAR | BUY | 2026-02-24 | $80.1M | — | Filing → |
| TBRA | BUY | 2016-11-02 | $628K | — | Filing → |